Search Results
Apr 17, 2026, 10:00 ET ScreenPoint Medical Secures $16M to Lead the Next Phase of AI in Breast Cancer Care
Medicine,[iv] ScreenPoint Medical's image-based breast cancer risk algorithm[v] outperformed other solutions (including Mirai, iCAD, and Google) at five-year risk prediction. Within the highest 14% of risk scores, the algorithm predicted 41.8% of all future cancers and 50.3% of interval
More news about: ScreenPoint Medical
Mar 05, 2026, 17:31 ET Global Companion Diagnostics Market to Register Immense Growth at a CAGR of ~12% by 2032 | DelveInsight
report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key AI in cancer diagnostics companies, including iCAD, Inc., ibex-ai, Roche Diagnostics, Kheiron Medical Technologies Limited, MVision AI Inc., Siemens Healthineers AG, GE HealthCare, NVIDIA Corporation,
More news about: DelveInsight Business Research, LLP
Feb 24, 2026, 11:35 ET AI Mammogram Technology Offers 23% Greater Cancer Detection, Fewer False Positives
ProFound AI mammogram solution from iCad, in early 2025, more than 4,000 patients have chosen the optional AI-enhanced as an optional supplement to their traditional screening. The software
More news about: Providence St. Joseph Hospital
Jan 27, 2026, 08:00 ET SimBioSys Appoints Senthil Periaswamy as Chief AI & Technology Officer
senior AI leadership roles at AstraZeneca, where he built predictive and patient-journey analytics supporting oncology and rare disease programs, and at iCAD, where as Chief Research Scientist and Senior Vice President of Clinical Innovation he led the development and clinical validation of multiple FDA-cleared
More news about: SimBioSys
Oct 30, 2025, 06:45 ET Intraoperative Radiation Therapy Market to Double by 2030 Driven by Precision Oncology and Growing Cancer Incidence | DataM Intelligence
Key Players: Carl Zeiss AG, Ariane Medical Systems Ltd., Eckert & Ziegler, Elekta AB, GMV, iCAD Inc., Moffitt Cancer Center, Xoft, Xinjiang Ke LAN Shuang Yi Medical Technology Stock Co., Ltd, E-Tech Industry Co., Ltd, and Derma Optic and Electronic
More news about: DataM Intelligence 4 Market Research LLP
Oct 08, 2025, 16:00 ET Visionary Holdings Inc. Announces 2025 Annual Meeting of Shareholders
and market the program in China, and served as the Director of the International Commercial Art Designer Association ("ICAD") in Toronto, Canada, where she managed the program for ICAD certification. She is the Executive Chairman of the Canada-China Economic and Trade Development Policy Committee, the
More news about: Visionary Holdings Inc.
Sep 02, 2025, 08:50 ET Medical Horizons and Bowhead Health Inc. Announce Exclusive Partnership to Bring AI-Powered Clinical Research Solutions to Italy, Turkey, and Cyprus
and impact. Medical Horizons has successfully introduced innovative AI platforms from companies such as Tempus Pixel, Cortechs.ai, AZmed, and iCAD into the Italian healthcare ecosystem, and collaborates closely with institutions such as the Campus Bio-Medico University Hospital of Rome.
More news about: Bowhead Health Inc.
Aug 04, 2025, 10:15 ET Brachytherapy Devices Market is Growing at CAGR of 6.7% During 2025 -2031 to Reach US$534.20 Million | The Insight Partners
WingMedanta Patents MAOLO Brachytherapy Device For Advanced Cervical Cancer TreatmentElekta Expands Brachytherapy Portfolio With Acquisition of iCad Inc.'s Xoft BusinessCivaTech Oncology Receives FDA Approval for CivaSheet Brachytherapy DeviceGet Premium Copy of Brachytherapy
More news about: The Insight Partners
Jul 11, 2025, 14:16 ET Artificial Intelligence (AI) in Radiology Market to Reach USD 4236 Million by 2031 | 9% CAGR Growth Driven by Cloud & On-Premise Solutions - Valuates Reports
Analysis)FujifilmAidocArterysLunitContextVisiondeepcOSVolpara Health Technologies LtdCureMetrixDensitasQView MedicalICADPurchase Regional Report:
More news about: Valuates Reports
Jun 10, 2025, 02:25 ET $TOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of SVT, SSBK, LNSR, iCAD to Protect Their Rights
obligation to you. iCAD, Inc. (NASDAQ: ICAD), relating to the proposed merger with RadNet,
More news about: Monteverde & Associates PC
Jun 09, 2025, 18:25 ET SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TTNP, LNSR, ICAD on Behalf of Shareholders
to learn more about your legal rights and options. iCAD, Inc. (NASDAQ: ICAD)'s sale to RadNet, Inc. for 0.0677 shares of RadNet common stock for each share of iCAD common stock. If you are an iCAD shareholder,
More news about: Halper Sadeh LLP